Skip to main content
Alfresa Holdings Corporation logo

Alfresa Holdings Corporation — Investor Relations & Filings

Ticker · 2784 ISIN · JP3126340003 T Wholesale and retail trade
Open in API
Filings indexed 66 across all filing types
Latest filing 2023-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 2784

About Alfresa Holdings Corporation

https://www.alfresa.com/eng/

Alfresa Holdings Corporation is a healthcare group that manages subsidiaries engaged in the wholesale, manufacturing, import, and export of pharmaceuticals, medical devices, and diagnostic reagents. The company's core business is pharmaceutical wholesaling, focusing on efficient supply chain management and stable delivery to medical institutions and pharmacies. In addition to its distribution network, the group also manufactures its own pharmaceutical products and operates a chain of dispensing pharmacies. Alfresa is committed to supporting the medical supply chain infrastructure, exploring innovative solutions such as drone technology for delivering pharmaceuticals.

Recent filings

Filing Released Lang Actions
四半期報告書－第20期第3四半期(2022/10/01－2022/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet and management analysis for the third quarter of the 20th fiscal period (ending December 31, 2022). It is a comprehensive financial report rather than an announcement or a summary, thus fitting the 'Interim / Quarterly Report' category. 9M 2023
2023-02-14 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO and CFO regarding the accuracy of the company's quarterly report (Interim Report). Since it is a regulatory filing confirming the validity of financial statements rather than the financial report itself, and does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2022-11-14 Japanese
四半期報告書－第20期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 1% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and corporate information for the second quarter of the 20th fiscal year (period ending September 30, 2022). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2023
2022-11-14 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO and CFO regarding the accuracy of the quarterly report (1st Quarter of the 20th fiscal year). Since this is a regulatory filing required by law to accompany financial reports but is not the financial report itself, and does not fit into specific categories like 'Earnings Release' or 'Interim Report', it falls under the 'Regulatory Filings' (RNS) category.
2022-08-12 Japanese
四半期報告書－第20期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the consolidated balance sheet, for the first quarter of the 20th fiscal year (April 1, 2022, to June 30, 2022). It includes management analysis, stock information, and audit review information, which aligns perfectly with the definition of an Interim/Quarterly Report (IR). Q1 2023
2022-08-12 Japanese
内部統制報告書－第19期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 1% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. Since it is a standalone audit-related report concerning internal control systems rather than a full annual report or a simple announcement, it falls under the 'Audit Report / Information' category.
2022-06-28 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.